Hunter Perkins Capital Management LLC purchased a new position in shares of Solesence, Inc. (NASDAQ:SLSN - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 437,872 shares of the company's stock, valued at approximately $1,909,000. Hunter Perkins Capital Management LLC owned approximately 0.62% of Solesence at the end of the most recent quarter.
Solesence Trading Down 7.6%
Solesence stock opened at $4.03 on Monday. The firm has a market capitalization of $284.03 million, a P/E ratio of 57.57 and a beta of 0.94. The company has a quick ratio of 0.84, a current ratio of 1.72 and a debt-to-equity ratio of 0.58. Solesence, Inc. has a 12 month low of $1.26 and a 12 month high of $16.56. The company has a 50 day moving average price of $3.46.
Solesence (NASDAQ:SLSN - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The company reported $0.04 earnings per share (EPS) for the quarter. Solesence had a return on equity of 32.99% and a net margin of 8.13%.The business had revenue of $20.36 million during the quarter.
Analysts Set New Price Targets
SLSN has been the topic of a number of research analyst reports. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Solesence in a report on Saturday, September 27th. Wall Street Zen upgraded Solesence from a "sell" rating to a "hold" rating in a research note on Sunday, August 3rd. One analyst has rated the stock with a Hold rating, According to MarketBeat, the stock presently has an average rating of "Hold".
Check Out Our Latest Report on SLSN
About Solesence
(
Free Report)
Nanophase Technologies Corporation provides engineered materials, formulation development, and commercial manufacturing with an integrated family of technologies in the United States. It offers surface engineered zinc oxide and titanium dioxide for sunscreens and personal care products; fully formulated cosmetics, sun care, and skin care under the Solésence brand name; and advanced materials products, such as architectural coatings, industrial coatings, abrasion-resistant additives, plastics additives, medical diagnostics, and various surface finishing technologies applications.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Solesence, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Solesence wasn't on the list.
While Solesence currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.